These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35203868)

  • 21. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Antibacterial Activity Between 1,4-Naphthoquinone and β-Lactam Antibiotics Against Methicillin-Resistant
    Yap JKY; Tan SYY; Tang SQ; Thien VK; Chan EWL
    Microb Drug Resist; 2021 Feb; 27(2):234-240. PubMed ID: 32589487
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.
    Rochon-Edouard S; Pestel-Caron M; Lemeland JF; Caron F
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3055-60. PubMed ID: 11036022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel adjuvant strategy to potentiate bacitracin against MDR MRSA.
    Kim JC; Jeon B
    J Antimicrob Chemother; 2016 May; 71(5):1260-3. PubMed ID: 26782772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic Activity of Lupinifolin in Combinations with Antibiotics Against
    Rattanakiat S; Kaewchang K; Thongsang S; Jaruchotikamol A; Pulbutr P
    Pak J Biol Sci; 2021 Jan; 24(6):656-662. PubMed ID: 34486341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects between aminoethyl-chitosans and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
    Lee DS; Kim YM; Lee MS; Ahn CB; Jung WK; Je JY
    Bioorg Med Chem Lett; 2010 Feb; 20(3):975-8. PubMed ID: 20036533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.
    Septama AW; Panichayupakaranant P
    Pharm Biol; 2016; 54(4):686-91. PubMed ID: 26427318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy between Ursolic and Oleanolic Acids from Vitellaria paradoxa Leaf Extract and β-Lactams against Methicillin-Resistant Staphylococcus aureus: In Vitro and In Vivo Activity and Underlying Mechanisms.
    Catteau L; Reichmann NT; Olson J; Pinho MG; Nizet V; Van Bambeke F; Quetin-Leclercq J
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29258194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
    Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
    J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus.
    Ferrer-González E; Kaul M; Parhi AK; LaVoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of synergy between SIPI-8294 and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    He M; Shao L; Liu Q; Li J; Lin H; Jing L; Li M; Chen D
    Lett Appl Microbiol; 2016 Jul; 63(1):3-10. PubMed ID: 27173151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of FtsZ Inhibition on the Localization of the Penicillin Binding Proteins in Methicillin-Resistant Staphylococcus aureus.
    Ferrer-González E; Huh H; Al-Tameemi HM; Boyd JM; Lee SH; Pilch DS
    J Bacteriol; 2021 Jul; 203(16):e0020421. PubMed ID: 34031040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effects between silibinin and antibiotics on methicillin-resistant Staphylococcus aureus isolated from clinical specimens.
    Kang HK; Kim HY; Cha JD
    Biotechnol J; 2011 Nov; 6(11):1397-408. PubMed ID: 21491604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergy of aminoglycoside antibiotics by 3-Benzylchroman derivatives from the Chinese drug Caesalpinia sappan against clinical methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Han ZQ; Hao XY; Han J; Li ZS; Wang GC
    Phytomedicine; 2014 Jun; 21(7):936-41. PubMed ID: 24703330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and characterization of methicillin-resistant Staphylococcus aureus carrying mecA or mecC and methicillin-susceptible Staphylococcus aureus in dairy sheep farms in central Italy.
    Giacinti G; Carfora V; Caprioli A; Sagrafoli D; Marri N; Giangolini G; Amoruso R; Iurescia M; Stravino F; Dottarelli S; Feltrin F; Franco A; Amatiste S; Battisti A
    J Dairy Sci; 2017 Oct; 100(10):7857-7863. PubMed ID: 28780098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCC
    AlSaleh A; Shahid M; Farid E; Kamal N; Bindayna K
    Access Microbiol; 2023; 5(2):. PubMed ID: 36910508
    [No Abstract]   [Full Text] [Related]  

  • 40. Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
    Banerjee R; Fernandez MG; Enthaler N; Graml C; Greenwood-Quaintance KE; Patel R
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):827-33. PubMed ID: 23340864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.